As people age or experience life events like childbirth, maintaining pelvic muscle strength can be challenging. While Kegel exercises are a well-known solution, they are often overlooked. Developed by Dr. Arnold Kegel in 1948, these exercises were initially intended to…
Advanced eClinical Training (ACT), a top provider of online career certification, has joined forces with the SEIU-UHW West & Joint Employer Education Fund (The Education Fund), which offers employer-funded education, training, and career support for union members in healthcare. This…
Results from the DESTINY-Breast12 phase 3b/4 trial reveal that ENHERTU® (trastuzumab deruxtecan) demonstrated significant clinical activity in HER2-positive metastatic breast cancer patients with brain metastases who had received up to two prior lines of therapy. These findings will be presented…
On August 28, 2024, Dongguk University Startup Technology Institute, LifestyledAI Co., Ltd., and UMUST R&D signed a joint MOU to collaborate on advancing global deep tech and healthcare initiatives. The partnership will leverage LifestyledAI’s innovative, proprietary AI technologies, currently patent-pending,…
Massive Bio, an AI-powered clinical trial matching platform, and Foundation Medicine have announced a strategic partnership to expand patient access to advanced clinical trials. The collaboration combines Massive Bio’s patient-matching technology with Foundation Medicine’s expertise in next-generation sequencing (NGS) and…
Genentech, part of the Roche Group, announced that the U.S. FDA has approved Ocrevus Zunovo™ (ocrelizumab & hyaluronidase-ocsq) for treating relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). Ocrevus Zunovo is the first twice-yearly, 10-minute subcutaneous injection administered…
Neuraptive Therapeutics, Inc. has announced that its therapy NTX-001 has received Breakthrough Therapy Designation from the FDA, which could accelerate its development for patients with peripheral nerve injuries that need repair. This designation is based on promising results from the…
ŌURA, the company behind the Oura Ring, has announced its acquisition of Veri, a Finnish firm specializing in personalized metabolic health. Veri, which partners with Oura to offer metabolic insights through continuous glucose monitors (CGMs), will see a significant portion…
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotech firm specializing in developing treatments for rare and serious diseases, has announced the pricing of its public offering. The company will sell 10,666,600 shares of common stock at $18.75 each and 20,000 shares…
Spencer Health Solutions (SHS), a leader in intelligent medication management technology, has announced its achievement of ISO 27001:2022 certification. This esteemed accreditation highlights SHS’s dedication to safeguarding patient data and maintaining top-tier information security standards. ISO 27001 is a globally…
Signet Healthcare Partners (“Signet”) has announced the successful sale of its portfolio company, Paragonix Technologies (“Paragonix”), to global medical technology leader Getinge. Paragonix, renowned for its advancements in organ transplantation and preservation, marks a significant acquisition for Getinge, enhancing its…
Contraline, Inc., a clinical-stage biotechnology firm, has signed an exclusive option-to-license agreement with the Population Council for the Nestorone/Testosterone Transdermal Gel (NES/T) for male contraception. If the option is exercised, Contraline will lead the global development and commercialization of NES/T,…